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Immune responseConsiderable efforts are currently focused on the biology of DC in view of their possible clinical use as adjuvant
for the generation of antigen-speciﬁc immunity and lifelong immunologic memory or for the treatment of
tumors. We assessed the role of Nattectin a C-type lectin identiﬁed in the Thalassophryne nattereri ﬁsh venom
in DC maturation. Nattectin induced a signiﬁcant neutrophilic recruitment into peritoneal cavity of mice,
followed by macrophages, with lipidic mediators and IL-12 p70 synthesis. Macrophages derived from 7 day-
Nattectin mice were CD11c+CD11blowLy6highF4/80Rhigh and express high levels of MHC class II and CD80
molecules. Culture of peritoneal exudates derived macrophages from 7 day Nattectin-mice and immature
BMDCs with Nattectin markedly increased the surface expression of CD40, CD80, CD86, and MHC class II in a
dose-dependent manner, and the production of MMP-2 and MMP-9 distributed in nucleus and cytoplasm of
cells, that was associated with strong activity in the culture supernatant. Nattectin treated DCs secreted IL-12
p70 and IL-10. The Nattectin-treated BMDC or macrophage-derived DCs were highly efﬁcient at Ag capture.
The speciﬁc immune response elicited by Nattectin was characterized by the production of speciﬁc antibodies
IgG1 and mainly IgG2a with IL-10 and IFN-γ synthesis by splenic cells. These results enable us to address that
Nattectin induces the recruitment of Ly6Chighmonocytes into the peritoneum,which exhibit a pro-inﬂammatory
proﬁle, where they differentiate into proliferating F4/80Rhigh macrophages. Macrophage-derived DCs mature in
the presence of the cytokine milieu generated against Nattectin, exhibiting T cell co-stimulatory molecule
expression and induced a Th1 polarized response.Applied Toxinology, Butantan
ão Paulo, Brazil. Tel.: +55 11
.
evier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Dendritic cells (DCs) represent an extremely plastic and versatile
cell type, which play a crucial role not only in the innate immunity and
initiation and control of adaptive immunity, but can also contribute to
the induction of tolerance. Immature DCs monitor the periphery,
capturing and processing of antigens (Ags). Monocytes represent an
abundant and heterogeneous population of circulating cells that can
be rapidly recruited to sites of inﬂammation and immune response
where they differentiate into DCs. Upon receiving danger signals
such as the presence of inﬂammatory cytokines, (IL-1, TNF-α) DCs
undergo phenotypic changes and migrate via lymphatics to local
lymph nodes. Immunogenic DCs present Ags in the context of MHC
along with co-stimulatory receptors and initiate T cell responses [1],
including rapidly polarizing the immune response to either Th1 or Th2types [2] and improving T cell memory [3]. The migration of immu-
nogenic DCs into secondary lymphoid tissues requires three major
classes of molecules: chemokines [4], which direct DCs to target
sites; adhesion molecules [5]; and matrix metalloproteinases (MMP)
involved in the degradation of the extracellular matrices (ECM), as
MMP-2 and MMP-9 [6,7].
Lectins are widely distributed from Caenorhabditis elegans to Homo
sapiens, that bind speciﬁcally and reversibly to carbohydrate struc-
tures, particularly the sugar moiety of glycoconjugates and glyco-
proteins. C-type lectins are proteins that contain a carbohydrate
recognition domain (CRDs) and bind carbohydrate structures in a
Ca2+-dependent manner. Calcium ions are directly involved in
ligand binding, as well as in maintaining the structural integrity of
the CRD that is necessary for the lectin activity, but many C-type
lectins are Ca+-independent and may not necessarily bind to sugar
ligands [8]. The speciﬁcity of C-type lectins can be generally divided
into two categories: a) the mannose (Man)-speciﬁc C-type lectins,
such as DC-SIGN, that possesses speciﬁcity for Man and/or fucose
(fuc) terminated glycans, b) and galactose- (Gal) speciﬁc C-type
lectins, such as macrophage galactose lectin, that recognize Gal- and
N-acetylgalactosamine (GalNAc) terminated glycans [9].
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lectin isolated from the electric organs of the eel Electrophorus electricus
[10], a substantial number of lectins have been identiﬁed in other
ﬁsh [11]. These lectins are distributed in the epidermis and also in the
epithelia of the upper digestive tract and gills, ﬂuids and cells where
they exhibit agglutinating or opsonizing activity against the ﬁsh path-
ogen Vibrio anguillarum [12,13]. The Indian catﬁsh (Clarias batrachus)
expresses a Ca2+-dependent galactose-speciﬁc serum lectin that sig-
niﬁcantly alters the viability and pathogenicity of various strains of
the bacteria Aeromonas and produces a dose-dependent increase in
bactericidal activity of ﬁsh macrophages [14].
Fish lectins have been extensively described within tissues and
cells associated with host defensive functions (branchial epithelium,
renal interstitium, hepatic sinusoidal, intestinal sub-mucosal granular
layer, skin and particularly within circulating granulocytes), however
only recently, a tetrameric lectin belonging to the family of mannose-
binding B-type was isolated from the mucus and sting of Scorpaena
plumieri venomous ﬁsh [15].
Recently, a C-type lectin Nattectin was identiﬁed in the venom of
the Brazilian venomous ﬁsh Thalassophryne nattereri, through cDNA
library, and by isolation with cation-exchange chromatography [16].
Nattectin revealed a single component with a pI of 9.73 andmolecular
mass of 15 kDa, containing six conserved cysteine residues, with one
CRD (QPD). The binding speciﬁcity of Nattectin for glycoproteins
was revealed to be Gal-β [1–3]-N-acetylgalactosamine, and Ca2+ is
indispensable for expressing their hemagglutination activity. We
also demonstrated that Nattectin induces neutrophil accumulation
into the peritoneum, demonstrating that it plays an important role in
defense systems against pathogens and parasites [17].
Considerable research efforts are currently focused on the biology
of DC in view of their possible clinical use as immune adjuvants for the
generation of antigen-speciﬁc immunity and lifelong immunologic
memory or for the treatment of chronic infectious diseases and
tumors [18–21]. Recently, Dai and coworkers [22] have shown that
Galectin-9 induces human DC maturation in vitro, as revealed by up-
regulation of the surface expression of co-stimulatory and HLA
molecules and of IL-12 production in a dose-dependent manner,
and that DCs treated with Gal-9 promote both T cell proliferation and
production of Th1 cytokines, suggesting that Gal-9 plays an important
role not only in innate immunity bymodulating granulocyte functions
but also in acquired immunity by inducing DC maturation.
Despite the importance of maturation state of dendritic cells in
initiatingadaptive immune responses and inDC-basedvaccine therapies,
the choice of reagent for DC maturation in vitro before administration
is critical. Here we reported for the ﬁrst time the effects of Nattectin, a
C-type lectin from venomous ﬁsh on the phenotypic and functional
maturation of murine bone marrow-derived DC (BMDC), and its in vivo
action in the development of innate and adaptive immune responses.
2. Material and methods
2.1. Animals
Male 8- to 10-week-old BALB/c mice were purchased from the
Butantan Institute (São Paulo, Brazil). Animalswere housed in a laminar
ﬂow holding unit (Gelman Sciences, Sydney, Australia) in autoclaved
cages on autoclaved bedding, in an air-conditioned room in a 12-hour
light/dark cycle. Irradiated food and acidiﬁed water were provided
ad libitum. All theprocedures involvinganimalswere in accordancewith
the guidelines provided by theAnimal Ethics committee of the Butantan
Institute, Brazil.
2.2. Reagents and Abs
Nattectin obtained by HPLC from T. nattereri venomwas conﬁrmed
byMALDI-TOFmass spectrometry (Amersham Biosciences) accordingto [17]. Endotoxin Detoxi-GelTM (Pierce Chemical Co.) was used
according to the manufacturer's instructions to remove N99% of the
contaminating LPS in the Nattectin solution (resulting in a total dose
b0.8 pg LPS), which was measured by Limulus Amoebocyte Lysate
(BioWhittaker). Recombinant mouse (rm) GM-CSF was purchased
from R&D Systems. ELISA kits for murine cytokines and chemokines or
lipidic mediators were purchased from BD Pharmingen or Cayman
Chemical, respectively. FITC-, PE- or PECy5-conjugated mAbs used to
detect the expression of CD11b (Mac-1α chain), CD11c (integrinαx),
CD4 (L3T4), CD8a (Ly2), CD45R/B220 (RA3-6B2), CD40 (3/23), CD80
(16-10A1), CD86 (GL1), IA/IE (M5/114.15.2), puriﬁed F4/80R (6 F12),
and Ly-6C (AL-21) by ﬂow cytometry, as well as isotype-matched
control mAbs, were purchased from BD Pharmingen. To detect MMP
localization, anti-MMP-2 and anti-MMP-9 from R&D Systems were
purchased (909-MM and 924-MP).
2.3. Nattectin-induced peritonitis
Different groups of mice were injected intraperitoneally (i.p.) with
10 μg of Nattectin diluted in 500 μl of sterile saline. Mice only injected
with saline were used as control. At time points indicated (1, 6, 24 h)
after injection, animals were killed by CO2 asphyxiation, peritoneal
cells were recovered by peritoneal lavage using 5 ml of ice-cold,
sterile PBS plus 0.1% EDTA. After lyses in Tris-buffered ammonium
chloride (pH 7.2) buffer and centrifugation, the supernatant from cell
suspension was collected for cytokine and chemokine analyses, and
the cell pellet was resuspended for leukocyte cell counts. Using a
hemocytometer and cytocentrifuge, slides were prepared, air dried,
ﬁxed in methanol, and stained (Wright-Giemsa, Scientiﬁc Products,
Chicago, IL). For differential cell counts, 300 leukocytes were enumer-
ated and identiﬁed as mononuclear cells or polymorphonuclear neu-
trophils, on the basis of staining andmorphologic characteristics using
Axio Imager A1 (Carl Zeiss, Germany).
2.4. Modulation of peritoneal macrophages by Nattectin
Peritoneal cells (5×105/ml) from 24 h or 7 day-Nattectin exudates
were seeded to plate substratum at 37 °C for 18 h. Non-adherent cells
were removed by washing with warm PBS and adhered macrophages
were in vitro re-stimulated with Nattectin (1 μg/ml) or medium alone.
After 4 h, the supernatants were stored for cytokines determination,
and adheredmacrophages werewashed, counted, and resuspended in
FACS buffer (1% BSA in PBS containing 0.01% NaN3). For phenotypic
analysis, cells (0.2–1×106 cells/stain) were initially incubated with
either 10% mouse serum or CD16/CD32 (Fc block) for 20 min at 4 °C.
Subsequently, cellswere incubatedwith FITC-, PE- or PECy5-conjugated
mAbs for CD11b (Mac-1 α chain), CD11c (integrin αx), CD40 (3/23),
CD80 (16-10A1), CD86 (GL1), IA/IE (M5/114.15.2), puriﬁed F4/80R
(6 F12), and Ly-6C (AL-21). All incubations were performed on ice
for 20 min and were followed by three washes with FACS buffer.
Appropriate isotype controls were used in all cases. For ﬂow cytometric
analysis, a typical forward and side scatter gate was set to exclude dead
cells and aggregates; a total of 104 events in the gate were analyzed
using a FACScalibur and Cell Quest Pro software (BD Biosciences, San
Jose, CA).
2.5. Generation of bone marrow derived DC
DCswere generated frommurine bonemarrow cells, as described by
Inaba et al. [23]. Brieﬂy, BM was ﬂushed from the tibiae and femurs of
naïve or Nattectin-injected BALB/c mice and depleted of red cells with
ammonium chloride. The cells were plated in culture plates (0.2×106
cells/ml; 8 ml/plate) in RPMI 42401 (Invitrogen Life Technologies) sup-
plemented with 10% heat-inactivated FBS, 2 mML-glutamine, 100 U/ml
penicillin, 100 μg/ml streptomycin, 0.1% 2-ME, 0,05 μg/ml asparagin/
vitamin, 10 mMHEPES (pH 7.4), 20 ng/ml rmGM-CSF at 37 °C, 5% CO2.
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mediumwas added. On day 6 and 8, half of freshmediumwas added to
the culture. On day 10, non-adherent cells and loosely adherent
proliferating DC aggregates were harvested for analysis or stimulation.
On the last day of culture, 94% or 71% more of the non-adherent cells
expressed CD11b or CD11c, respectively (data not shown).
2.6. Stimulation of immature DC by Nattectin
Nattectin (0.1, 1, and 10 μg/ml) or sterile PBS alone was added to
cultures of isolated immature DC in six-well plates (106 cells/ml;
3 ml/well). Following treatment with increasing concentrations of
Nattectin for 24 h, DC viability was analyzed using an annexin V
binding assay (BD Biosciences) according to the manufacturer's
guidelines. We tested whether Nattectin activity is mediated by
their carbohydrate-binding activity; therefore, different concentra-
tions of lactose (10 or 30 mM) were added to the culture medium,
with sucrose at the same concentration serving as a control. The
medium used in the culture, to stimulate DC with Nattectin, was
supplemented with GM-CSF, because the ability of DC to capture Ag is
lost if DC are cultured without GM-CSF.
2.7. Effect of Nattectin on endocytosis of peritoneal macrophages
and BMDC
Peritoneal-derivedmacrophages orBMDC fromcontrol- orNattectin-
mice obtained after 7 day pos-injection were washed, resuspended in
complete medium, and treated with 1 μg/ml of Nattectin at 4 °C for 4 h.
After washing, cells (1×106/ml) were then incubated at 37 °C with
0.1 mg/ml of FITC-dextran (0.431-μm,Sigma–Aldrich, St Louis,MO,USA)
for 90 min. Uptake was stopped by adding cold PBS containing 2% FCS
and 0.01% NaN3. Cells were then washed four times and analyzed by
ﬂow cytometry (FACSCalibur, BD-Pharmingen, San Diego, CA, USA).
Results of endocytosis of FITC-dextran were expressed as mean ﬂuo-
rescence intensity.
2.8. Flow cytometric analysis
Cells (106) were incubated in staining buffer (PBS with 2% FBS and
0.1% sodium azide) containing anti-CD16/CD32 Ab (FcγIII/II, BD
Pharmingen, San Diego, CA) for 30 min on ice to block the nonspeciﬁc
binding of Igs. Cellswere stainedwith ﬂuorochrome-conjugatedmAb at
a concentration of 0.5 μg/106. Cells stainedwith the appropriate isotype-
matched Igwere used as negative controls. After staining, the cells were
ﬁxedwith 2%w/v formaldehyde analyzed immediately on a FACScaliber
ﬂow cytometer using CellQuest 3.1 software (Becton Dickinson, San
Jose, CA). The instrumenthad a standardopticalﬁlter conﬁgurationwith
bandpassﬁlters of 530/30-nmand 585/44-nm for FL1 (FITC-conjugated
antibodies) and FL2 (PE-conjugated antibodies) data acquisition,
respectively. For the analysis of forward-angle light scatter, side-angle
light scatter, and cell surface receptor expression, data were acquired in
real time. Data were recorded as geometricmeanﬂuorescence intensity
(MFI) and percent ﬂuorescent-positive cells. The instrument was
standardizedbeforephenotypic analysiswithCalibrationbeads (Fluoro-
Spheres 6-Peak; Dako Cytomation, Carpinteria, CA) and cleaned with
sequential washes of distilled water, 10%vol/vol hypochlorite and dis-
tilled water before data acquisition.
2.9. Quantitation of cytokines and chemokines
Culture supernatantswere analyzed by ELISA. The OD450 of triplicate
samples was determined and corrected by a microplate reader, with
readings at 570 nm. The minimum detection levels for IL-1β, IL-6,
TNF-α, andMCP-1was 7.8 pg/ml and for KC, IL-10, IL-12 p70, and IFN-γ
was 15.6 pg/ml.2.10. Eicosanoid assays
Concentrations of LTB4 and PGE2 were measured in the peritoneal
exudate lavage ﬂuid collected 6 h after Nattectin or saline injection, by
a speciﬁc enzymatic immunoassay, using a commercial kit (Cayman
Chemicals, MI, USA). In brief, 100 μl aliquots of each sample were in-
cubated with the eicosanoid conjugated with acetylcholinesterase and
the speciﬁc rabbit antiserum in 96-well microtitration plates, coated
with anti-rabbit IgG mouse monoclonal antibody. After addition of the
substrate, the absorbances of the samples were recorded at 412 nm in a
microplate reader, and concentration of the eicosanoid was estimated
from standard curve.
2.11. Immunocytochemical localization of matrix
metaloproteinases (MMPs)
In 8-well tissue culture coated slides, 106 immature DC were
cultured in the presence of 10 μg/ml of Nattectin for 24 h according to
Brooks et al., [24] and Yu and Stamenkovic, [25]. After washing slides
were air-dried and then ﬁxed with 4% formaldehyde in PBS and
incubated in this ﬁxative for 20 min at RT. Samples were washed once
with PBS for 5 min. Cells were permeabilized with 1% Triton X-100 in
PBS for 10 min and then washed with PBS. To block nonspeciﬁc
binding sites, Dako block (Life Technologies) was applied for 10 min
at room temperature. Samples were incubated for 1 h with primary
antibodies to MMP-2 and MMP-9 at a concentration of 20 ng/ml in
Dako sample dilution buffer (Life Technologies). After several rinses
with PBS, the samples were incubated with secondary antibody for
30 min (Mouse IgG RPE Goat F(Ab)2; Dako). After washings and
drying, slides were mounted with ProLong Antifade Kit (Molecular
Probes, Eugene, OR). A number of controls were performed to verify
the speciﬁcity of the antibodies that were used in this study. No signal
was detected when the primary or secondary antibody was used
alone (data not shown). Isotype controls were always stained in
parallel. Samples were viewed with an Axio Imager A1, Carl Zeiss
(Germany) microscope with 63× and 100× objectives (NA=1.4).
MMP-2- and 9-speciﬁc immunoreactivity was quantiﬁed in that the
number of positive cells per ﬁeld of vision at 100× magniﬁcation was
counted by two independent investigators (TSC and CL).
2.12. MMP activity measurement
Supernatants from immature DC cultured with Nattectin were
supplemented with an equal volume of zymograph sample buffer
containing 4% SDS (Bio-Rad, Hercules, CA, USA). The sample mixture
was incubated for 10 min at room temperature and loaded into a 10%
SDS-polyacrylamide gel containing 0.1% gelatin. Following electro-
phoresis, the gel was incubated in 2.5% Triton X-100 for 30 min at
room temperature and then incubated in a buffer containing
50 mmol/l Tris, 0.2 mmol/l NaCl, 5 mmol/l CaCl 2 and 0.02% Brij-35
(pH 7.6) at 37 C for 10 h. Subsequently, the gel was stainedwith 0.25%
Coomassie Brilliant Blue for 3 h at room temperature and destained in
a buffer containing 30% methanol and 10% glacial acetic acid for
visualizing bands of enzymatic activity. Puriﬁed murine MMP-2 and
MMP-9 was used as a size marker.
2.13. Generation of immune response for Nattectin
In order to characterize the immune responses to Nattectin, mice
(n=5/group) were intraperitoneally (i.p.) injected two times with
Nattectin (10 μg at 7-day intervals) with 1.6 mg Al(OH)3 as adjuvant.
Control animals were immunized only with adjuvant on day 0.
Fourteen days after the ﬁrst immunization mice were bled and the
humoral immune responses weremonitored by Abs titer and cytokine
production by Ag-speciﬁc splenic cells.
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Fig. 1. Nattectin shows pro-inﬂammatory activity in a murine model of peritonitis. At
different time points (1 h — A, 6 h — B and 24 h — C) after i.p. injection of 10 μg of the
Nattectin animals were killed and peritoneal cavities were washed for total, neutrophils,
and macrophage cell count. Mice only injected with saline were considered as control.
The results represent the mean±SEM. * pb0.05 compared with control-group.
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Plasma was tested for IgG1 or IgG2a antibodies using Nattectin-
coated 96-well plates and biotinylated goat anti-mouse IgG1 and
IgG2a antiserum. The reactions were developed with streptavidin–
horseradish peroxidase complex (Sigma Chemical Co. St. Louis, Mo,
USA), O-phenylenediamine (OPD) and H2O2 and the plates were
read at 490 nm on an automated ELISA reader (Victor 3, Multilabel
Counter, PerkinElmer). The results were expressed as themean±SEM
absorbance.
2.15. Statistical analysis
All values were expressed as mean±SEM. Parametric data were
evaluated using analysis of variance, followed by the Tukey test for
multiple comparisons. Non-parametric data were assessed using the
Mann–Whitney test. Differences were considered statistically signif-
icant at pb0.05. The SPSS statistical package (Release 8.0, Standard
Version, 1997) was employed.
3. Results
3.1. Nattectin shows pro-inﬂammatory activity in murine
model of peritonitis
Neutrophils are rapidly mobilized from the blood to the site of
inﬂammation during acute inﬂammatory reactions. To determine the
type of leukocytes being recruited into the peritoneal cavity of mice
following Nattectin challenge, we performed cytospins and leukocyte
differential counts on the peritoneal exudates. Leukocyte recruitment
progressively increased into the peritoneum of mice challenged with
Nattectin over the ﬁrst 1 h, which was maintained at 24 h. Nattectin
induced a 4.5-fold increase in neutrophil numbers, beginning at 1 h
and increasing until 6 h thereafter (Fig. 1A and B). Neutrophil counts
were diminished at 24 h, concomitant with a signiﬁcant increase in
peritoneal macrophage inﬁltration (Fig. 1C).
The eicosanoid mediators and inﬂammatory cytokines are known
to function as a potent neutrophil chemoattractant. As shown in Fig. 2,
peritonitis inducedbyNattectinwas accompanied by elevated levels of
LTB4 (Fig. 2A) and PGE2 (Fig. 2B) mediators as well as IL-1β (Fig. 2C)
and IL-6 (Fig. 2D). In addition, Nattectin promoted the release of CXC
and CC, chemokines controlling neutrophils and macrophage recruit-
ment, KC (CXCL8) and MCP-1 (CCL2), respectively (Fig. 1A and 3B).
Following Nattectin challenge, IL-12 p70 levels signiﬁcantly increase
in the peritoneal exudates at 24 h (Fig. 3C) and after 6 h, a sustained
release of IL-10 was observed (Fig. 3D). Nattectin did not induce
detectable amounts of TNF-α or NO in peritoneal exudates (data not
shown).
3.2. Nattectin induces the differentiation of macrophage into cells
exhibiting typical DC function
To further characterize peritoneal-derivedmacrophages inNattectin-
mice, we examined the expression of macrophage/DC markers, co-
stimulatory molecules and the production of cytokines. As expected,
peritoneal-derived macrophages from control exudates were CD11c+
and express high levels of CD11b, F4/80R, and Ly6C (control bars,
Fig. 4A). Peritoneal-derived macrophages from 24 h-Nattectin exudates
were CD11c+and express low levels of CD11b, and were negative
for Ly6C or F4/80R (gray bars, Fig. 4A). Peritoneal-derived CD11c+
CD11blow macrophages from 7 day-Nattectin exudates have intensi-
ﬁed expression of Ly6C (167-fold) and F4/80R (161-fold) (black bars,
Fig. 4A).
Low levels of CD80, CD86, and MHC class II were observed in
peritoneal-derived macrophages from control- or 24 h-Nattectin
exudates (Fig. 4B, control and gray bars, respectively). Peritoneal-derived macrophages from 7 day-Nattectin exudates expressed high
levels of CD80 and mainly MHC class II (Fig. 4B, black bars). Thus, mac-
rophages derived from 7 day-Nattectin mice were CD11c+CD11blow
Ly6high F4/80Rhigh and express high levels of MHC class II and CD80
molecules.
Of interest, peritoneal-derived macrophages from 24 h-Nattectin
exudates stimulated in vitrowith medium alone produced IL-6 and IL-
12 p70 cytokines (Fig. 5A and 5B). The level of IL-12 p70 in peritoneal-
derived macrophages from 24 h-Nattectin exudates remained high
after re-stimulation with Nattectin, and also peritoneal-derived
macrophages from 7 day-Nattectin exudates induced bioactive IL-12
p70 cytokine production after re-stimulation with Nattectin (Fig. 5B).
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6 or 24 h after i.p. injection. The results represent the mean±SEM. * pb0.05 compared with control-group.
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Dextran is a representative Ag that is taken up by DCs primarily
via speciﬁc mannose receptor-mediated endocytosis with a minor
component of uptake due to constitutive ﬂuid phase pinocytosis [26].*
0
1000
2000
3000
4000
K
C 
(p
g/m
L)
Cont NTC Cont NTC Cont NTC
1 h 6 h 24 h
IL
-1
2p
70
 (p
g/m
L)
0
5000
10000
15000
20000
*
Cont NTC Cont NTC Cont NTC
1 h 6 h 24 h
C
A
Fig. 3. Chemokines and immunomodulators induced by Nattectin. At different time points
peritoneal exudates were analyzed for KC (A), MCP-1 (B), IL-12 p70 (C) and IL-10 (D) by s
group.Here we determined whether peritoneal-derived macrophages
had augmented endocytic activity after incubation with FITC-dextran
particles. As depicted in Fig. 5C, Nattectin increased the endocytic
capacity of peritoneal-derived macrophages from 7 day-Nattectin
exudates (1.3-fold), consistent with an immunogenic APC functional
phenotype.*
*
0
1000
2000
3000
4000
M
CP
-1
 (p
g/m
L)
Cont NTC Cont NTC Cont NTC
1 h 6 h 24 h
0
1500
3000
4500
6000
IL
-1
0 
(p
g/m
L)
*
Cont NTC Cont NTC Cont NTC
1 h 6 h 24 h
D
*
B
(1 h, 6 h and 24 h) after i.p. injection of 10 μg of the Nattectin animals were killed and
peciﬁc ELISA. The results represent the mean±SEM. * pb0.05 compared with control-
BCD11c CD11b Ly6C F4/80R
0
50
Control NTC 24h NTC 7d
100
125
150
175
* * *
*
*
*
*
in
cr
ea
se
 in
 M
FI
 o
f p
os
iti
ve
Pe
cM
Ø
 (%
)
CD80 CD86 MHC class II
0
25
50
75
Control NTC 24h NTC 7d
*
*
*
in
cr
ea
se
 in
 M
FI
 o
f p
os
iti
ve
Pe
cM
Ø
 (%
)
A
Fig. 4. Increase of co-stimulatory molecules on macrophage-derived DC by Nattectin.
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To clarify whether Nattectin had in vivo effects on BM cell dif-
ferentiation into DCs, mice were killed 7 days after injection of saline
or Nattectin for BMDC culture. Expansion of BMDC from femur of 7 day-
Nattectin mice in the presence of GM-CSF throughout a period of
10 days led to a 2.7 (±0.4)-fold increase in total cell number compared
to BMDC recovered in control-mice (Fig. 6A). In Fig. 6B, CD11c+MHC
class II+BMDC fromNattectin-miceexpressed signiﬁcantlymoreCD40,
CD80, and CD86 than BMDC from control-mice.
3.4. In vitro effects of Nattectin on DC maturation
We next addressed the question of whether Nattectin acts on DC
maturation in in vitro assay. The bone marrow cells from naïve mice
incubated with GM-CSF exhibiting a typical phenotype of immature
DCs (CD11bhighCD11c+CD8αneg B220low) with moderate levels of
MHC class II molecules, but low expression of CD40, CD86, and CD80
as expected (Fig. 7A).
The abundant expression of CD40, CD80, CD86, and MHC class II
molecules resembles the phenotype of mature DC, originally deﬁned
as cells that have an increased capacity to stimulate T cell pro-
liferation. After exposure to different concentrations of Nattectin for24 h, the cells acquired a mature phenotype, dose dependently up-
regulating the expression of co-stimulatory molecules, mainly at
10 μg/ml (Fig. 7A). We monitored herein DC survival on exposure to
Nattectin. We found that all concentrations (0.1, 1, and 10 μg/ml)
capable of modulating DC phenotype failed to affect DC viability
(data not shown).
IL-12 production by DCs is strongly linked to maturation state. In
addition, Nattectin greatly increased the production of IL-12 p70
(Fig. 7B) and also induced a signiﬁcant increase of IL-10 secretion
(Fig. 7C). The up-regulation of the expression of co-stimulatory
molecules or cytokine production by Nattectin were not suppressed
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representative of four independent experiments.
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shown), conﬁrming that the β-galactoside-binding activity of
Nattectin is not essential for this lectin to induce DC maturation.
Since polymyxin B, an LPS inhibitor, showed no inhibitory effect on
Nattectin-induced cytokine secretion, it seems likely that the activity
of Nattectin is derived from its self-function rather than due to trace
amounts of contamination of endotoxin.
The expression of surface molecules and IL-12 p70 secretion indi-
cated that exposure to Nattectin signiﬁcantly induced the phenotypic
maturation of in vivo (Fig. 5C) and in vitro generated DC (Fig. 7B).
Then, BMDC from naïve mice exhibited high capacity to take up FITC-
dextran after Nattectin stimulation compared to unstimulated BMDC
(3.4±0.2-fold, Fig. 7D).
After antigen acquisition, DCs undergo phenotypic changes and
migrate via lymphatics to local lymph nodes. To accomplish this re-
quires not only that DC follow chemoattractant gradients, but also
that they produce MMPs enabling them to traverse the extracellular
matrix. Immunocytochemistry analysis demonstrated a strong stain-
ing of MMP-9 into the cytoplasm and on the surface of Nattectin-DCs
(Fig. 8D), and some DCs expressed MMP-2 (Fig. 8B). This induction of
MMP-9 by Nattectin was associated with strong activity (83 kDa) in
the culture supernatant of BMDC (right, Fig. 8E).
3.5. Nattectin primes Th1 phenotype in vivo
Immunogenic DCs are able to drive T-cell clonal expansion and
differentiation, and prime immune responses. We next determinedthe nature of the cellular immune response elicited by Nattectin in
mice. To this end, 14 days after the ﬁrst immunization with Nattectin,
spleens were removed from mice immunized twice with Nattectin
plus alum adjuvant and cells were in vitro re-stimulated with 10 μg of
Nattectin. As seen in Fig. 9, upon in vitroNattectin re-challenge, spleen
lymphocytes from Nattectin-mice produced the stimulatory cytokine
IFN-γ (Fig. 9A) as well as the anti-inﬂammatory cytokine IL-10
(Fig. 9B). In contrast, there was no production of IL-2, IL-4, IL-5 or IL-
12 p70 by spleen cells after stimulation with Nattectin (data not
shown).
As a further assessment of the ability of Nattectin activated DC to
prime an adaptive immune response in vivo, we measured the
antibody production in mice. Th1 cells help B cells switch to IgG2a
production, whereas Th2 cells are associated with the production of
IgG1. Mice immunized with Nattectin had a signiﬁcantly stronger
speciﬁc IgG2a response (Fig. 9C), but moderate levels of speciﬁc IgG1
(Fig. 9D), indicative of a Th1 shift.
4. Discussion
C-type lectins are a main kind of pattern recognition molecule in
the innate immune system. It has become clear that by binding a
variety of carbohydrate structures, particularly the sugar moiety of
glycoconjugates and glycoproteins both on the cell surface and in
ECM, lectins deliver signals intracellularly as well as mediate cell–cell
and cell–ECM adhesion [27]. Lectins thus modulate development,
inﬂammatory, autoimmune, and infectious diseases, and tumor
metastasis. Fish have evolved natural immune modulators such as
galectins and C-type lectins with widespread tissue distribution,
which are able to counter the host defense against microbial
pathogens.
In the study presented here, we describe the biological character-
ization of Nattectin from the venom of the Brazilian venomous ﬁsh T.
nattereri. In vivo characterization identiﬁed that Nattectin, a galactose-
speciﬁc lectin belonging to the family of C-type lectins, has potent
pro-inﬂammatory properties, promoting leukocyte recruitment into
peritoneal cavity of mice, and has been shown to be dependent on the
induction of several lipidic mediators, cytokines, and chemokines,
including CXCL1 (KC) and CCL2 (MCP-1), which are high-afﬁnity
ligands for CXCR1/CXCR2 and CCR2, respectively. In murine perito-
nitis, rapid up-regulation of KC precedes the recruitment of
neutrophils into peritoneum that is followed by MCP-1 up regulation
and monocyte inﬂux, culminating in resolution of leukocyte inﬂam-
mation [28,29].
Many human galectins have shown pro-inﬂammatory activities
in vitro and in vivo [22,30,31]. Gal-8 modulates neutrophil function
via interaction with integrin alphaM [32] and Gal-3 can function as a
chemokine, inducing migration of human monocytes and macro-
phages [33]. Similar to chemokines, this activity is mediated through a
pertussis toxin (PTX)-sensitive (G-protein-coupled) pathway and asso-
ciatedwith aCa2+ inﬂux, and thus a speciﬁc chemokine receptor(s)may
be involved. If Nattectin also drives leukocyte mobilization by directly
acting on chemokine receptor expressed on the cell surface it remains
to be elucidated.
Furthermore, the pro-inﬂammatory properties of Nattectin were
reinforced by the induction of IL-12 p70 production in the peritoneal
exudates. The production of the bioactive p70 form of IL-12 is tightly
regulated and involves separate control of the production of the p40
and p35 components by factors such as microbial products, the CD40
ligand CD154, stimulation from activated T cells, and the appropriate
cytokine milieu. Thus, it appears that pro-inﬂammatory mediators
as IL-1β, IL-6 and PGE2 also present in the peritoneal exudates of
Nattectin-mice seem to cooperate to license macrophages to differ-
entiate into cells exhibiting typical DC function [34–37].
Differentiation of monocytes/macrophages into dendritic cells
in vivo has been well documented [38,39]. Our results presented here
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by Nattectin Ag, differentiated into mature DC, as evidenced by up-
regulation of Ly6C, F4/80R, CD80 andMHC class II. Thesemacrophage-
derived DCs exhibit functional attributes (augmented Ag presenta-
tion capacity with avid phagocytosis, high T cell co-stimulatory mol-
ecules expression, and enhanced capacity to activate T cells by the
production of IFN-γ through the high-level of bioactive IL-12 p70
secretion), which may be important to activate T cells in vivo.
Subsequently we assessed the effects of Nattectin on DC functional
activation using a comprehensive in vitro assay: BMDC generated by
GM-CSF uniformly expresses high levels of CD11bhigh CD11c+CD8αneg
B220low putative of myeloid-related BMDC subset [40]. Our results
showed that exposure of immature BMDC to Nattectin induced phe-
notypic changes characterized by enhanced expression of molecules
involved in antigen presentation (MHC class II) and in co-stimulation(CD40, CD80, CD86), concordant with conventional activation of DC
by LPS or CD40L. The interaction between CD40L on CD4+ T cells and
CD40 on dendritic cells has been shown to be indispensable for T cell
activation and differentiation [41]. Thus, the up-regulation of CD40
expression and other co-stimulatory molecules in DC induced by
Nattectin may contribute to signiﬁcantly enhanced DC stimulatory
function in driving T cells proliferation. Interestingly, these experi-
ments clearly conﬁrmed the stimulatory effect of Nattectin on DC
maturation by demonstrating, among other events: the loading of
MHC class II molecules on the cell surface of DCs, elevated IL-12 p70
production, and capacity of DCs to migrate via the lymphatics and
home to the T cell-rich area of lymph nodes, through its effect on
production and release of active MMP-9 [42,43].
Therefore, these results enable us to address that Nattectin induces
the recruitment of Ly6Chigh monocytes into the peritoneum, which
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proliferating F4/80Rhigh macrophages, probably positive for CCR2 and
CD62L. These cells mature in the presence of the cytokine milieu
generated against Nattectin, exhibiting T cell co-stimulatory molecule
expression and acquire antigen and transport it to draining lymph
node. In addition, our results demonstrated that in response to in-
ﬂammation signals derived from Nattectin, monocytes can move
quickly to sites of infection and differentiate into macrophages and
DCs and bone marrow cells are also able to differentiate into mature
DCs.
We also detected in a peritonitis model or in vitro DC maturation,
both stimulatedwith Nattectin the production of IL-10, a cytokine that
modulates both innate and adaptive immunity, primarily by exertinganti-inﬂammatory effects. This ﬁnding addresses the question con-
cerning the role of concomitant IL-10 and IL-12 p70 production in-
duced by Nattectin. We reasoned that the failure in TNF-α and NO
production by Nattectin-injected mice could be the result of anti-
inﬂammatory effects of IL-10 [44] potentiated by regulatory effect
of PGE2, such as has been proposed in models of inﬂammation in-
volving the action of IL-1β and IL-10 [45,46].
Lastly, we therefore tested whether phenotypic changes induced
by Nattectin supported the DC capacity to stimulated speciﬁc T cell
expansion and Th1 differentiation during a close DC–T-cell interac-
tion. Our in vivo results demonstrate that Nattectin induced a Th1
polarized response, characterized by high levels of speciﬁc IgG2a
and Ag-speciﬁc IFN-γ-producing cells in vivo. These cells also did not
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1555T.C. Saraiva et al. / International Immunopharmacology 11 (2011) 1546–1556produce IL-4 or IL-5, indicating that Th2 cells were not differentiated.
In addition, we found that Th1 response induced by Nattectin is
probablymodulated by the anti-inﬂammatory cytokine IL-10, because
the latter is produced concomitantly with IFN-γ in immunized mice.
Recently Rutz and coworkers [47] identiﬁed Notch signaling as a
potent inducer of IL-10 both in developing and in already established
IFN-γ-secreting Th1 cells. This effect requires co-stimulation by the
cytokines IL-12 or IL-27 that depends on signal transducer and activator
of transcription 4 (STAT4) signaling, conﬁrming the role of Notch de-
pendent Th1-derived IL-10 under inﬂammatory conditions in the
protection of the host from Th1-induced pathology independently ofregulatory T cells [48,49]. Moreover, DCs that matured in response to
Gal-9, like those treated with glucocorticoids or PGE2 [50,51] also
stimulate T cells responsible for IL-10 synthesis.
Collectively, Nattectin is a novel venomous ﬁsh C-type lectin with
potent pro-inﬂammatory capacity. This lectin acts modifying the
biological responses through the control of recruitment and activa-
tion of monocytes/macrophages, licensing these cells to differentiate
into cells exhibiting typical DC function. There is a general consensus
that fully activated DC, expressing appropriate markers of phenotypic
activation and secreting a Th1 proﬁle of inﬂammatory cytokines, will
be optimal for the priming of speciﬁc T cell-mediated anti-tumor
1556 T.C. Saraiva et al. / International Immunopharmacology 11 (2011) 1546–1556immunity by Ag-loaded DC [52]. Thus, Nattectin represent an optimal
candidate adjuvant for Ag-loaded DC by its immunomodulatory
activity for selecting Th1-dominant response.
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